New anti-peptic ulcer drug, Ilaprazole on phase III clinical study.

Il Yang announced that the new anti-peptic ulcer drug, Ilaprazole that was designated as one of the national strategic study projects, was successfully completed with its phase II clinical study in 5 overseas countries including Australia and Singapore for the past 3 years, and now a global phase III studies including Korea will soon undertake after the settlement of study project with GCRC (Gl...